Dyansys, Inc. FDA Approvals

0 new drug approvals and 6 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product	What it is	Route	Decided
Primary Relief510(k)Sep 13, 2022Neurology	Neurology	510(k)Substantially Equivalent (Traditional)	Sep 13, 2022
Drug Relief v1510(k)Jun 6, 2022Neurology	Neurology	510(k)Substantially Equivalent (Special)	Jun 6, 2022
ANSiStim-PP510(k)May 12, 2022Neurology	Neurology	510(k)Substantially Equivalent (Traditional)	May 12, 2022
Primary Relief510(k)Jan 31, 2022Neurology	Neurology	510(k)Substantially Equivalent (Traditional)	Jan 31, 2022
First Relief510(k)Dec 20, 2021Neurology	Neurology	510(k)Substantially Equivalent (Traditional)	Dec 20, 2021
Drug Relief v1510(k)Nov 5, 2021Neurology	Neurology	510(k)Substantially Equivalent (Traditional)	Nov 5, 2021